-
- Ishikawa Tetsuya
- Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Japan
-
- Tatsumi Yasuaki
- Department of Medical Biochemistry, Faculty of Pharmaceutical Sciences, Toho University, Japan
-
- Kato Koichi
- Department of Medicine, Aichi Gakuin University School of Pharmacy, Japan
-
- Hayashi Yumi
- Department of Integrated Health Sciences, Nagoya University Graduate School of Medicine, Japan
-
- Imai Norihiro
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan
-
- Ito Takanori
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan
-
- Ishizu Youji
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan
-
- Ishigami Masatoshi
- Department of Gastroenterology and Hepatology, Nagoya University Graduate School of Medicine, Japan
-
- Nihei Wataru
- Department of Medicine, Aichi Gakuin University School of Pharmacy, Japan
-
- Kato Ayako
- Department of Medicine, Aichi Gakuin University School of Pharmacy, Japan
-
- Hayashi Hisao
- Department of Medicine, Aichi Gakuin University School of Pharmacy, Japan
抄録
<p>A 59-year-old Japanese woman presented with hyperferritinemia. We decided against iron removal treatment because there were no symptoms or signs of iron-induced organ damage. A follow-up study revealed a gradual increase in transferrin saturation. The patient underwent a second examination at 66 years old. A liver biopsy showed substantial iron deposits in hepatocytes and Kupffer cells but no inflammation or fibrosis. Serum hepcidin-25 levels were highly parallel with hyperferritinemia. A genetic analysis revealed a G80S mutation in SLC40A1. These features are compatible with those of ferroportin disease. The patient remained asymptomatic at 70 years old, suggesting that the iron-loading condition may have been benign. </p>
収録刊行物
-
- Internal Medicine
-
Internal Medicine advpub (0), 2024
一般社団法人 日本内科学会